Intensive Treatment Versus Standard Weekly Prolonged Exposure for Adults With Post-Traumatic Stress Disorder
Efficacy, Mechanisms of Change and Cost Effectiveness of Intensive Exposure-based Treatment for PTSD: a Randomized Controlled Trial
Karolinska Institutet
140 participants
Sep 4, 2023
INTERVENTIONAL
Conditions
Summary
The goal of this clinical trial is to compare a novel, massed treatment format of prolonged exposure to gold standard trauma focused cognitive behavioral therapy (weekly delivered prolonged exposure) for post-traumatic stress disorder. The objective with this study is to investigate efficacy, mechanisms of change and cost effectiveness of intensive prolonged exposure (I-PE) in regular Swedish psychiatric care. Adult patients with post-traumatic stress disorder will be randomly assigned to receive either gold standard prolonged exposure weekly for 15 weeks or 5 days of intensive treatment with the addition of three booster sessions dispersed 1, 2 and 4 weeks after completion of the massed treatment period. Qualitative interviews will be conducted with therapists to explore their experiences of delivering intensive treatment for PTSD, with particular focus on perceived benefits and challenges, clinical processes, patient engagement, and the impact of the intensive format on therapeutic work.
Eligibility
Inclusion Criteria5
- years of age or above,
- Primary PTSD diagnosis
- Fluent in Swedish
- Sign informed consent
- Able to attend either I-PE or 15 weekly sessions of PE
Exclusion Criteria4
- Initiation or adjustment of any psychotropic medication within the last 4 weeks prior to commencement of treatment
- Serious mental health symptoms, such as mania, psychosis, alcohol, or substance use disorders or current suicide risk warranting immediate clinical attention
- Ongoing evidence-based trauma-focused psychological treatment
- Ongoing trauma-related threat (e.g. living with a violent spouse)
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Intensive treatment with prolonged exposure
Weekly delivered prolonged exposure sessions for 15 weeks
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05934175